{"id":"https://openalex.org/W7225327696","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","title":"447 Molecular and immunological characterization of anti-PD-L1 response in GEMM-derived melanoma cell lines","display_name":"447 Molecular and immunological characterization of anti-PD-L1 response in GEMM-derived melanoma cell lines","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225327696","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0447"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0447","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A501.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A501.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031747537","display_name":"Bharat Ashok Rajmalani","orcid":"https://orcid.org/0000-0001-6097-3080","observed_orcids":["https://orcid.org/0000-0001-6097-3080"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bharat Ashok Rajmalani","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160805991","display_name":"Jason B Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason B Williams","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160914379","display_name":"Hirien Modi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hirien Modi","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016263029","display_name":"Alexander L. Kley","orcid":"https://orcid.org/0009-0003-8384-9674","observed_orcids":["https://orcid.org/0009-0003-8384-9674"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Kley","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071532092","display_name":"Kyle Deans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Deans","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422947","display_name":"Jiang Zhang","orcid":"https://orcid.org/0000-0001-7392-8270","observed_orcids":["https://orcid.org/0000-0001-7392-8270"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiang Zhang","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160743826","display_name":"Shiyi Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shiyi Wang","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091128223","display_name":"Thomas Seth Kupper","orcid":"https://orcid.org/0000-0002-4229-2916","observed_orcids":["https://orcid.org/0000-0002-4229-2916"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Kupper","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1283280774"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A501","last_page":"A501"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8730000257492065},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.859000027179718},{"id":"https://openalex.org/keywords/genetically-engineered-mouse-models","display_name":"genetically engineered mouse models","score":0.7599999904632568},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.621999979019165},{"id":"https://openalex.org/keywords/immunoediting","display_name":"immunoediting","score":0.7239999771118164},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.7070000171661377},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.5049999952316284},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2780480104","wikidata":"https://www.wikidata.org/wiki/Q18351145","display_name":"Immunoediting","level":4,"score":0.8414999842643738},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7049000263214111},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.673799991607666},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6391000151634216},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.578499972820282},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4957999885082245},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4851999878883362},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.47519999742507935},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4542999863624573},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.44609999656677246},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.44530001282691956},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4383000135421753},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.415800005197525},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.40869998931884766},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.37220001220703125},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3562999963760376},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.35109999775886536},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.32100000977516174},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30079999566078186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29440000653266907},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2752000093460083},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2750000059604645},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2721000015735626},{"id":"https://openalex.org/C81089528","wikidata":"https://www.wikidata.org/wiki/Q5134986","display_name":"clone (Java method)","level":3,"score":0.27079999446868896},{"id":"https://openalex.org/C132351222","wikidata":"https://www.wikidata.org/wiki/Q7454699","display_name":"Serial passage","level":3,"score":0.26589998602867126},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.265500009059906},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.258899986743927},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.25699999928474426},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.2522999942302704},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.2506999969482422}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0447","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A501.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0447","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0447","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A501.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225327696.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3154074238","https://openalex.org/W2405841169","https://openalex.org/W2505562885","https://openalex.org/W2734739695","https://openalex.org/W7169875253","https://openalex.org/W4312075223","https://openalex.org/W2615188404","https://openalex.org/W4313383729","https://openalex.org/W2098598928","https://openalex.org/W1422101183"],"abstract_inverted_index":{"Background":[0],"Tumor":[1],"cell":[2,71,154,244,321],"lines":[3,80,125,155,179,322],"from":[4],"genetically":[5],"engineered":[6,28],"mouse":[7],"models":[8],"are":[9,18],"widely":[10],"used":[11,135],"to":[12,33,40,47,68,86,136,210,247,297,327],"study":[13,328],"cancer":[14],"immunity,":[15],"but":[16],"many":[17],"weakly":[19],"immunogenic":[20],"and":[21,46,53,66,73,82,89,115,131,142,161,181,237,268,273,308,317,333],"lack":[22],"a":[23,162,196,263,324],"traceable":[24],"tumor":[25,44,95,213,221,243,311],"antigen.":[26],"We":[27],"the":[29,35,54,202,227,253,309],"Braf/PTEN":[30],"melanoma":[31,70,153,320],"model":[32,36],"express":[34],"antigen":[37,45],"EGFPOVA":[38,74,88,165,207],"(BPO)":[39],"enable":[41],"tracking":[42],"of":[43,56,195],"interrogate":[48],"tumor\u2013immune":[49],"coevolution,":[50],"checkpoint":[51,299],"sensitivity,":[52],"determinants":[55],"anti-programmed":[57],"death-ligand":[58],"1":[59],"(PD-L1)":[60],"response.Methods":[61],"Tumors":[62],"were":[63,84,126,183,189,259],"enzymatically":[64],"digested":[65,147],"cultured":[67],"derive":[69],"lines,":[72,256],"expression":[75,101,166],"was":[76,102,118,134],"assessed.":[77],"Two":[78],"EGFPOVA-positive":[79,178],"(891.BPO":[81,180],"2742.BPO)":[83,182],"purified":[85,177],"100%":[87,206],"serially":[90],"passaged":[91],"in":[92,107,120,158,173,250,283,287,313],"vivo,":[93,232],"with":[94,156,170],"take":[96],"monitored":[97],"across":[98],"passages.":[99],"PD-L1":[100,225],"analyzed":[103],"directly":[104],"ex":[105,231],"vivo":[106],"early":[108,228],"(P0)":[109,230],"versus":[110],"late":[111],"(P4)":[112,222],"passage":[113,194,229],"tumors,":[114,148],"anti-PD-L1":[116,129,248,257,315],"therapy":[117,249],"tested":[119],"vivo.":[121,251],"Five":[122],"EGFPOVA-negative":[123,255],"BPO":[124],"evaluated":[127],"for":[128,305],"responsiveness,":[130],"whole-exome":[132],"sequencing":[133,279],"compare":[137],"mutational":[138,292],"burden":[139,293],"between":[140],"responder":[141,284],"non-responder":[143,288],"lines.Results":[144],"From":[145],"328":[146],"approximately":[149],"~16%":[150],"(55/328)":[151],"yielded":[152],"continuous":[157],"vitro":[159],"growth":[160],"condensed":[163],"morphology.":[164],"varied":[167],"widely,":[168],"consistent":[169],"dynamic":[171],"immunoediting":[172],"primary":[174],"tumors.":[175],"When":[176],"engrafted":[184],"into":[185],"mice,":[186],"most":[187],"tumors":[188],"spontaneously":[190],"rejected;":[191],"however,":[192],"serial":[193],"rare":[197],"escape":[198],"variant,":[199],"while":[200],"at":[201],"same":[203],"time":[204],"maintaining":[205],"expression,":[208],"led":[209],"progressively":[211],"higher":[212,224],"take,":[214],"indicating":[215],"stepwise":[216],"immune":[217,239,329],"escape.":[218],"The":[219],"late-passage":[220],"expressed":[223],"than":[226,286],"suggesting":[233],"increased":[234],"IFN\u03b3":[235],"responsiveness":[236],"adaptive":[238],"resistance.":[240],"Accordingly,":[241],"this":[242],"line":[245],"responded":[246],"Among":[252],"five":[254],"responses":[258],"heterogeneous:":[260],"605.BPO":[261,285],"showed":[262,270,275],"strong":[264],"response;":[265],"1876.BPO,":[266],"736.BPO,":[267],"1845.BPO":[269],"intermediate":[271],"responses;":[272],"3142.BPO":[274],"no":[276],"response.":[277,335],"Whole-exome":[278],"revealed":[280],"fewer":[281],"mutations":[282],"3142.BPO,":[289],"arguing":[290],"that":[291],"alone":[294],"is":[295],"insufficient":[296],"predict":[298],"sensitivity.Conclusions":[300],"These":[301],"data":[302],"highlight":[303],"roles":[304],"neoantigen":[306],"quality":[307],"evolving":[310],"microenvironment":[312],"shaping":[314],"outcomes":[316],"establish":[318],"BPO-derived":[319],"as":[323],"versatile":[325],"platform":[326],"editing,":[330],"escape,":[331],"resistance,":[332],"immunotherapy":[334]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}